SRF114

Poster: SRF114, an Afucosylated Anti-CCR8 Antibody, Depletes Intratumoral Treg Cells and Inhibits Tumor Growth

Society for Immunotherapy of Cancer Annual Meeting, November 2022

Publication: Fc-optimized anti-CCR8 antibody depletes regulatory T cells in human tumor models

American Association for Cancer Research, March 2021

Poster: SRF114 is a Fully Human, CCR8-Selective IgG1 Antibody that Induces Destruction of Tumor Tregs Through ADCC

Society for Immunotherapy of Cancer Annual Meeting, November 2020